Short answer
STAAR SURGICAL CO (STAA) filed an 8-K current report with the SEC on March 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q4 and full-year FY2025 results reported (fiscal year ended January 2, 2026).
STAAR SURGICAL CO 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year FY2025 results reported (fiscal year ended January 2, 2026)
- Full financials in Exhibit 99.1: press release is the primary source for revenue, margins, and guidance
- STAA reports on a 52/53-week fiscal calendar; year-end date signals standard fiscal close
Item 7.01 · Regulation FD Disclosure
- Earnings call scheduled March 3, 2026 at 5:30 p.m. ET covering Q4 and full-year results ended January 2, 2026
- Dual Interim Co-CEOs presenting: COO and CFO sharing top role signals ongoing leadership transition
- Shareholder letter filed as Exhibit 99.2 contains substantive financial results and commentary
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other STAAR SURGICAL CO 8-K filings
Get the next STAA 8-K as it lands
Follow STAA for push alerts, or ask the research agent what this filing means.